A dual-targeting peptide facilitates targeting anti-inflammation to attenuate atherosclerosis in ApoE −/− mice

Authors:

Abstract
We report a peptidic dual-targeting drug delivery platform (integrins targeting and self-assembly instructed by matrix metalloproteinases) towards inflamed endothelial cells, which improved the anti-inflammatory ability of the loaded drug (i.e., puerarin) in vitro and thus improved the antiatherogenic effect of the loaded drug (i.e., puerarin) in vivo.
Funding Information
  • National Natural Science Foundation of China (31671025)
  • National Natural Science Foundation of China (31771060)
  • National Natural Science Foundation of China (31771099)
  • National Natural Science Foundation of China (81871504)
  • National Natural Science Foundation of China (81971765)
  • Natural Science Foundation of Guangdong Province (201707010203)

This publication has 31 references indexed in Scilit: